Dr. Osborn is interested role of the autonomic nervous system in long-term control of cardiovascular function and the pathogenesis of cardiometabolic diseases. The primary focus of his laboratory the role of renal nerves in the pathogenesis and maintenance of hypertension. This is motivated by clinical trials of targeted sympathetic ablation in humans using medical devices. Dr. Osborn’s laboratory is investigating the mechanisms of organ specific sympathetic nerve activity in the maintenance of neurogenic hypertension as a translational platform for development of novel antihypertensive therapies in the very near future. Dr. Osborn is Director of the Minnesota Center for Autonomic Neuromodulation which is leading a 7-center global study of the effects of vagal nerve modulation on physiological systems in human subjects.
Dr. Osborn’s research efforts are concentrated on therapies for the treatment of cardiovascular and metabolic diseases. He has made important contributions to our understanding the role of the sympathetic nervous system in the pathogenesis of hypertension. Dr. Osborn is also an internationally recognized expert in the development of autonomic neuromodulation therapies.
Specialty
Cardiovascular - IBP
Neurophysiology - IBP